159 related articles for article (PubMed ID: 28330493)
1. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
2. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Lee S; Stewart S; Nagtegaal I; Luo J; Wu Y; Colditz G; Medina D; Allred DC
Cancer Res; 2012 Sep; 72(17):4574-86. PubMed ID: 22751464
[TBL] [Abstract][Full Text] [Related]
3. Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
Brock EJ; Jackson RM; Boerner JL; Li Q; Tennis MA; Sloane BF; Mattingly RR
PLoS One; 2021; 16(5):e0252314. PubMed ID: 34048471
[TBL] [Abstract][Full Text] [Related]
4. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Eiseler T; Döppler H; Yan IK; Goodison S; Storz P
Breast Cancer Res; 2009; 11(1):R13. PubMed ID: 19243594
[TBL] [Abstract][Full Text] [Related]
6. Essential role of STAT5a in DCIS formation and invasion following estrogen treatment.
Dees S; Pontiggia L; Jasmin JF; Sotgia F; Lisanti MP; Mercier I
Aging (Albany NY); 2020 Aug; 12(14):15104-15120. PubMed ID: 32633727
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.
Bischel LL; Beebe DJ; Sung KE
BMC Cancer; 2015 Jan; 15():12. PubMed ID: 25605670
[TBL] [Abstract][Full Text] [Related]
8. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
[TBL] [Abstract][Full Text] [Related]
9. LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c.
Deshpande RP; Sharma S; Liu Y; Pandey PR; Pei X; Wu K; Wu SY; Tyagi A; Zhao D; Mo YY; Watabe K
Breast Cancer Res; 2022 Jan; 24(1):6. PubMed ID: 35078502
[TBL] [Abstract][Full Text] [Related]
10. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.
Hu M; Peluffo G; Chen H; Gelman R; Schnitt S; Polyak K
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3372-7. PubMed ID: 19218449
[TBL] [Abstract][Full Text] [Related]
11. The metastasis-associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin.
Thuma F; Ngora H; Zöller M
Mol Oncol; 2013 Oct; 7(5):917-28. PubMed ID: 23727360
[TBL] [Abstract][Full Text] [Related]
12. TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression.
Gibson SV; Tomas Bort E; Rodríguez-Fernández L; Allen MD; Gomm JJ; Goulding I; Auf dem Keller U; Agnoletto A; Brisken C; Peck B; Cameron AJ; Marshall JF; Jones JL; Carter EP; Grose RP
NPJ Breast Cancer; 2023 Mar; 9(1):9. PubMed ID: 36864079
[TBL] [Abstract][Full Text] [Related]
13. Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?
Zhang X; Hashemi SS; Yousefi M; Ni J; Wang Q; Gao L; Gong P; Gao C; Sheng J; Mason J; Man YG
Int J Biol Sci; 2008 Aug; 4(5):259-69. PubMed ID: 18726004
[TBL] [Abstract][Full Text] [Related]
14. Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications.
Wright S; Burkholz SR; Zelinsky C; Wittman C; Carback RT; Harris PE; Blankenberg T; Herst CV; Rubsamen RM
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511584
[TBL] [Abstract][Full Text] [Related]
15. Isogenic Mammary Models of Intraductal Carcinoma Reveal Progression to Invasiveness in the Absence of a Non-Obligatory In Situ Stage.
Bernhardt SM; Mitchell E; Stamnes S; Hoffmann RJ; Calhoun A; Klug A; Russell TD; Pennock ND; Walker JM; Schedin P
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190184
[TBL] [Abstract][Full Text] [Related]
16. A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies.
Wang CC; Bajikar SS; Jamal L; Atkins KA; Janes KA
Nat Cell Biol; 2014 Apr; 16(4):345-56. PubMed ID: 24658685
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS3 restricts cancer invasion in models of early breast cancer progression through enhanced fibronectin degradation.
Gibson SV; Madzharova E; Tan AC; Allen MD; Keller UAD; Louise Jones J; Carter EP; Grose RP
Matrix Biol; 2023 Aug; 121():74-89. PubMed ID: 37336268
[TBL] [Abstract][Full Text] [Related]
18. Myoepithelial Cells: Their Origin and Function in Lacrimal Gland Morphogenesis, Homeostasis, and Repair.
Makarenkova HP; Dartt DA
Curr Mol Biol Rep; 2015 Sep; 1(3):115-123. PubMed ID: 26688786
[TBL] [Abstract][Full Text] [Related]
19. BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression.
Elsarraj HS; Hong Y; Limback D; Zhao R; Berger J; Bishop SC; Sabbagh A; Oppenheimer L; Harper HE; Tsimelzon A; Huang S; Hilsenbeck SG; Edwards DP; Fontes J; Fan F; Madan R; Fangman B; Ellis A; Tawfik O; Persons DL; Fields T; Godwin AK; Hagan CR; Swenson-Fields K; Coarfa C; Thompson J; Behbod F
NPJ Breast Cancer; 2020; 6():12. PubMed ID: 32352029
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.
Farina AR; Mackay AR
Cancers (Basel); 2014 Jan; 6(1):240-96. PubMed ID: 24473089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
